BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30099370)

  • 1. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.
    Provenzale D; Gupta S; Ahnen DJ; Markowitz AJ; Chung DC; Mayer RJ; Regenbogen SE; Blanco AM; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Hall MJ; Halverson AL; Hamilton SR; Hampel H; Klapman JB; Larson DW; Lazenby AJ; Llor X; Lynch PM; Mikkelson J; Ness RM; Slavin TP; Sugandha S; Weiss JM; Dwyer MA; Ogba N
    J Natl Compr Canc Netw; 2018 Aug; 16(8):939-949. PubMed ID: 30099370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
    Bevers TB; Helvie M; Bonaccio E; Calhoun KE; Daly MB; Farrar WB; Garber JE; Gray R; Greenberg CC; Greenup R; Hansen NM; Harris RE; Heerdt AS; Helsten T; Hodgkiss L; Hoyt TL; Huff JG; Jacobs L; Lehman CD; Monsees B; Niell BL; Parker CC; Pearlman M; Philpotts L; Shepardson LB; Smith ML; Stein M; Tumyan L; Williams C; Bergman MA; Kumar R
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1362-1389. PubMed ID: 30442736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular Carcinoma: Updates to Screening and Diagnosis.
    Covey AM
    J Natl Compr Canc Netw; 2018 May; 16(5S):663-665. PubMed ID: 29784751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer.
    Choi Y; Sateia HF; Peairs KS; Stewart RW
    Semin Oncol; 2017 Feb; 44(1):34-44. PubMed ID: 28395761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
    Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
    CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.
    Williams CD; Grady WM; Zullig LL
    J Natl Compr Canc Netw; 2016 Nov; 14(11):1479-1485. PubMed ID: 27799515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020.
    Provenzale D; Ness RM; Llor X; Weiss JM; Abbadessa B; Cooper G; Early DS; Friedman M; Giardiello FM; Glaser K; Gurudu S; Halverson AL; Issaka R; Jain R; Kanth P; Kidambi T; Lazenby AJ; Maguire L; Markowitz AJ; May FP; Mayer RJ; Mehta S; Patel S; Peter S; Stanich PP; Terdiman J; Keller J; Dwyer MA; Ogba N
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1312-1320. PubMed ID: 33022639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis.
    Mannucci A; Zuppardo RA; Rosati R; Leo MD; Perea J; Cavestro GM
    World J Gastroenterol; 2019 Jun; 25(21):2565-2580. PubMed ID: 31210710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
    Dollinger MM; Behl S; Fleig WE
    Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
    Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
    BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
    Gupta S; Provenzale D; Regenbogen SE; Hampel H; Slavin TP; Hall MJ; Llor X; Chung DC; Ahnen DJ; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Markowitz AJ; Mayer RJ; Ness RM; Samadder NJ; Shike M; Sugandha S; Weiss JM; Dwyer MA; Ogba N
    J Natl Compr Canc Netw; 2017 Dec; 15(12):1465-1475. PubMed ID: 29223984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in Screening Tests and Strategies for Colorectal Cancer.
    Sovich JL; Sartor Z; Misra S
    Biomed Res Int; 2015; 2015():326728. PubMed ID: 26504799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.
    Yu C; Skootsky S; Grossman M; Garner OB; Betlachin A; Esrailian E; Hommes DW; May FP
    Clin Transl Gastroenterol; 2018 Sep; 9(8):177. PubMed ID: 30177700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Characteristics of Who Undergoes Testing Is Crucial for the Development of Diagnostic Strategies to Identify Individuals at Risk for Early-age Onset Colorectal Cancer.
    Vajravelu RK; Mehta SJ; Lewis JD;
    Gastroenterology; 2021 Mar; 160(4):993-998. PubMed ID: 33444572
    [No Abstract]   [Full Text] [Related]  

  • 16. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastrointest Endosc; 2017 Jul; 86(1):18-33. PubMed ID: 28600070
    [No Abstract]   [Full Text] [Related]  

  • 17. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal occult blood testing for colorectal cancer screening: the past or the future.
    Benton SC; Seaman HE; Halloran SP
    Curr Gastroenterol Rep; 2015 Feb; 17(2):428. PubMed ID: 25673567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
    Carroll PH; Mohler JL
    J Natl Compr Canc Netw; 2018 May; 16(5S):620-623. PubMed ID: 29784740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.